Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 70001-70050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05935618
Occupational Therapy Rehabilitation for Frail Elders with Dysphagia
NARecruiting
30 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05979350
Metagenomic NGS for Diagnosis of Pneumonia
NAActive, not recruiting
100 participants
Started: Aug 7, 2023 · Completed: Oct 30, 2025
2 conditions3 sponsors1 location
NCT06037018
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
PHASE1Recruiting
44 participants
Started: Aug 7, 2023 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT05579470
Expanding Medication-Assisted Therapies in Central Asia
NARecruiting
900 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2026
1 condition5 sponsors4 locations
NCT06270381
Empower-Grief: A Study on a Selective Intervention to Prevent Prolonged Grief Disorder
NARecruiting
44 participants
Started: Aug 7, 2023 · Completed: Nov 1, 2024
1 condition1 sponsor1 location
NCT05453396
Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
PHASE2Recruiting
40 participants
Started: Aug 7, 2023 · Completed: Jul 6, 2027
11 conditions1 sponsor1 location
NCT05956756
Resilience Programming for Occupational Therapy Students
NARecruiting
130 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06125860
BEP Targeting Strategies in Ethiopia
NARecruiting
6,750 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2025
8 conditions3 sponsors1 location
NCT05896137
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
PHASE2Recruiting
50 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor12 locations
NCT05809258
Supraclavicular Versus Axillary Block for Arteriovenous (AV) Fistula Creation
NARecruiting
120 participants
Started: Aug 7, 2023 · Completed: May 31, 2025
3 conditions1 sponsor1 location
NCT05992077
Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia
NARecruiting
21,000 participants
Started: Aug 7, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor4 locations
NCT05856890
HepB mAb19 in Individuals With Chronic Hepatitis B Infection
PHASE1Recruiting
37 participants
Started: Aug 7, 2023 · Completed: Mar 30, 2028
2 conditions2 sponsors2 locations
NCT05956860
Radial Access for Abdominopelvic Vascular Intervention
N/ARecruiting
1,143 participants
Started: Aug 7, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05879224
Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia
NARecruiting
11,250 participants
Started: Aug 7, 2023 · Completed: Jul 31, 2025
2 conditions13 sponsors6 locations
NCT05970016
A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.
PHASE1/PHASE2Recruiting
56 participants
Started: Aug 7, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06863727
The Beijing Longitudinal Disability Survey in Community Elderly
N/ARecruiting
1,962 participants
Started: Aug 7, 2023 · Completed: Jul 31, 2028
5 conditions2 sponsors1 location
NCT06013189
Re-Adjustment of Sweep Gas Flow to the During the Rewarming Period of the Cardiopulmonary Bypass
N/ARecruiting
90 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2034
2 conditions1 sponsor1 location
NCT05834491
A Novel Approach to Plantar Fasciitis in the Aging Population
PHASE2Recruiting
138 participants
Started: Aug 7, 2023 · Completed: May 31, 2025
1 condition3 sponsors1 location
NCT05874271
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
NARecruiting
900 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2025
2 conditions8 sponsors4 locations
NCT05979883
Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning
NAActive, not recruiting
204 participants
Started: Aug 7, 2023 · Completed: Dec 16, 2025
3 conditions1 sponsor6 locations
NCT05981183
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
NARecruiting
20 participants
Started: Aug 7, 2023 · Completed: Jan 7, 2026
1 condition1 sponsor1 location
NCT05896124
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
PHASE2Active, not recruiting
75 participants
Started: Aug 7, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor16 locations
NCT05876312
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 7, 2023 · Completed: Sep 30, 2026
1 condition3 sponsors4 locations
NCT05594238
Leveraging Virtual Care Strategies to Improve Access and Treatment for Individuals With Alcohol Use Disorders
NARecruiting
400 participants
Started: Aug 7, 2023 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT05992298
Feasibility Testing of 7-Tesla Magnetic Resonance Imaging
NARecruiting
780 participants
Started: Aug 7, 2023 · Completed: Feb 29, 2028
1 condition1 sponsor1 location
NCT05993832
Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
NARecruiting
40 participants
Started: Aug 7, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06329765
CUped: An Approach to Motor Recovery Post-Stroke, Not Compensation
NARecruiting
12 participants
Started: Aug 7, 2023 · Completed: Apr 4, 2027
2 conditions2 sponsors1 location
NCT05984979
The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes
N/AActive, not recruiting
60 participants
Started: Aug 7, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT06001151
Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative
PHASE2Recruiting
49 participants
Started: Aug 7, 2023 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT06040437
Be-Prox. An Effectiveness Study of Bullying Intervention in Norwegian Kindergartens.
NAActive, not recruiting
2,500 participants
Started: Aug 7, 2023 · Completed: Jul 1, 2026
1 condition4 sponsors4 locations
NCT05939739
Study of the Value of Trio Exome Sequencing in the Etiological Assessment of Specific Non-syndromic Language and Learning Disorders
NARecruiting
101 participants
Started: Aug 7, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05963100
Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Aug 7, 2023 · Completed: May 16, 2026
1 condition1 sponsor1 location
NCT05763420
Clinical Efficacy of AH Plus Bioceramic Sealer
NAEnrolling by invitation
212 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05712161
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
NAActive, not recruiting
15 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2033
4 conditions1 sponsor5 locations
NCT05553041
18F-Fluciclovine PET-MRI in High-grade Glioma
EARLY_PHASE1Recruiting
30 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2026
5 conditions3 sponsors1 location
NCT05851391
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
PHASE2Recruiting
30 participants
Started: Aug 7, 2023 · Completed: Apr 30, 2027
7 conditions2 sponsors1 location
NCT06049667
A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
PHASE1Recruiting
72 participants
Started: Aug 7, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05972629
A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria
PHASE1/PHASE2Active, not recruiting
32 participants
Started: Aug 7, 2023 · Completed: Apr 2, 2030
1 condition1 sponsor11 locations
NCT04932122
Outcomes After Dorsal Wrist Ganglia Excision With or Without PIN
NAEnrolling by invitation
32 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2028
4 conditions1 sponsor2 locations
NCT06033781
Cognitive-Behavioral Therapy for Children With Nightmares
NARecruiting
90 participants
Started: Aug 7, 2023 · Completed: Jan 1, 2026
3 conditions2 sponsors2 locations
NCT06786546
Type 1 Diabetes Autonomic and Vascular Function
N/AEnrolling by invitation
72 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2029
3 conditions2 sponsors1 location
NCT06543290
Azithromycin Before Induction
PHASE1Recruiting
400 participants
Started: Aug 7, 2023 · Completed: Aug 7, 2026
1 condition1 sponsor1 location
NCT05024175
Long-term Follow-up of Subjects Treated With CAR T Cells
N/ARecruiting
45 participants
Started: Aug 7, 2023 · Completed: Aug 1, 2039
7 conditions1 sponsor1 location
NCT05990582
The Alkmaar MLPTI Cohort Study: Outcomes at 9 Years
NAEnrolling by invitation
140 participants
Started: Aug 6, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05641649
Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets
PHASE4Active, not recruiting
16 participants
Started: Aug 6, 2023 · Completed: Nov 30, 2023
1 condition2 sponsors2 locations
NCT05139589
The ENDOCARDITIS AUMC Data Collection
N/ARecruiting
3,000 participants
Started: Aug 6, 2023 · Completed: Dec 31, 2030
3 conditions1 sponsor1 location
NCT06008769
Therapy for People With Opioid Use Disorder
NAActive, not recruiting
20 participants
Started: Aug 6, 2023 · Completed: Aug 31, 2024
1 condition2 sponsors1 location
NCT06572501
Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Lateral Position
NARecruiting
200 participants
Started: Aug 6, 2023 · Completed: Jan 31, 2030
3 conditions1 sponsor1 location
NCT06835426
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NARecruiting
150 participants
Started: Aug 6, 2023 · Completed: Jun 30, 2027
13 conditions1 sponsor1 location
NCT05542485
PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study
N/ARecruiting
97 participants
Started: Aug 6, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor3 locations